Cargando…
Developing clinical practice guidelines for the integration of Chinese medicine and biomedicine: A new process()
INTRODUCTION: Despite the integration of Chinese medicine and biomedicine which has emerged in clinical practice worldwide, a comprehensive development process for clinical practice guidelines (CPG) has up to now been missing. A valid method for the rational use of predictions for herb-drug interact...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier GmbH.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102766/ https://www.ncbi.nlm.nih.gov/pubmed/32288885 http://dx.doi.org/10.1016/j.eujim.2016.11.013 |
_version_ | 1783511904707149824 |
---|---|
author | Shi, Nannan Zhong, Linda L.D. Zhang, Chi Han, Xuejie Wang, Yuexi Liu, Yuqi Wang, Liying Liu, Mengyu Lu, Aiping |
author_facet | Shi, Nannan Zhong, Linda L.D. Zhang, Chi Han, Xuejie Wang, Yuexi Liu, Yuqi Wang, Liying Liu, Mengyu Lu, Aiping |
author_sort | Shi, Nannan |
collection | PubMed |
description | INTRODUCTION: Despite the integration of Chinese medicine and biomedicine which has emerged in clinical practice worldwide, a comprehensive development process for clinical practice guidelines (CPG) has up to now been missing. A valid method for the rational use of predictions for herb-drug interaction is a biggest challenge in guideline development process. METHODS: This article summarises the development process by reviewing key literature from CPG developers. It focuseson key methods and challenges specific to CPGs for integration by using text mining and bioinformatics to provide a powerful adjunct to CPG development. RESULTS: The guideline development process identified, together with new approaches, incorporates evidence-based methodology and provides better decisions through analysis of uncertain herb-drug interaction. CONCLUSIONS: This new process used three basic phases (preparation, development, and finalization) and seven steps providing a set of methodological principles for CPG development intergrating Chinese medicine and biomedicine. |
format | Online Article Text |
id | pubmed-7102766 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Published by Elsevier GmbH. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71027662020-03-31 Developing clinical practice guidelines for the integration of Chinese medicine and biomedicine: A new process() Shi, Nannan Zhong, Linda L.D. Zhang, Chi Han, Xuejie Wang, Yuexi Liu, Yuqi Wang, Liying Liu, Mengyu Lu, Aiping Eur J Integr Med Article INTRODUCTION: Despite the integration of Chinese medicine and biomedicine which has emerged in clinical practice worldwide, a comprehensive development process for clinical practice guidelines (CPG) has up to now been missing. A valid method for the rational use of predictions for herb-drug interaction is a biggest challenge in guideline development process. METHODS: This article summarises the development process by reviewing key literature from CPG developers. It focuseson key methods and challenges specific to CPGs for integration by using text mining and bioinformatics to provide a powerful adjunct to CPG development. RESULTS: The guideline development process identified, together with new approaches, incorporates evidence-based methodology and provides better decisions through analysis of uncertain herb-drug interaction. CONCLUSIONS: This new process used three basic phases (preparation, development, and finalization) and seven steps providing a set of methodological principles for CPG development intergrating Chinese medicine and biomedicine. Published by Elsevier GmbH. 2016-12 2016-11-30 /pmc/articles/PMC7102766/ /pubmed/32288885 http://dx.doi.org/10.1016/j.eujim.2016.11.013 Text en © 2016 Published by Elsevier GmbH. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Shi, Nannan Zhong, Linda L.D. Zhang, Chi Han, Xuejie Wang, Yuexi Liu, Yuqi Wang, Liying Liu, Mengyu Lu, Aiping Developing clinical practice guidelines for the integration of Chinese medicine and biomedicine: A new process() |
title | Developing clinical practice guidelines for the integration of Chinese medicine and biomedicine: A new process() |
title_full | Developing clinical practice guidelines for the integration of Chinese medicine and biomedicine: A new process() |
title_fullStr | Developing clinical practice guidelines for the integration of Chinese medicine and biomedicine: A new process() |
title_full_unstemmed | Developing clinical practice guidelines for the integration of Chinese medicine and biomedicine: A new process() |
title_short | Developing clinical practice guidelines for the integration of Chinese medicine and biomedicine: A new process() |
title_sort | developing clinical practice guidelines for the integration of chinese medicine and biomedicine: a new process() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102766/ https://www.ncbi.nlm.nih.gov/pubmed/32288885 http://dx.doi.org/10.1016/j.eujim.2016.11.013 |
work_keys_str_mv | AT shinannan developingclinicalpracticeguidelinesfortheintegrationofchinesemedicineandbiomedicineanewprocess AT zhonglindald developingclinicalpracticeguidelinesfortheintegrationofchinesemedicineandbiomedicineanewprocess AT zhangchi developingclinicalpracticeguidelinesfortheintegrationofchinesemedicineandbiomedicineanewprocess AT hanxuejie developingclinicalpracticeguidelinesfortheintegrationofchinesemedicineandbiomedicineanewprocess AT wangyuexi developingclinicalpracticeguidelinesfortheintegrationofchinesemedicineandbiomedicineanewprocess AT liuyuqi developingclinicalpracticeguidelinesfortheintegrationofchinesemedicineandbiomedicineanewprocess AT wangliying developingclinicalpracticeguidelinesfortheintegrationofchinesemedicineandbiomedicineanewprocess AT liumengyu developingclinicalpracticeguidelinesfortheintegrationofchinesemedicineandbiomedicineanewprocess AT luaiping developingclinicalpracticeguidelinesfortheintegrationofchinesemedicineandbiomedicineanewprocess |